ConductScience.org, home

Paper26323879

The global burden of IBD: from 2015 to 2025.

Kaplan GG. Nat Rev Gastroenterol Hepatol, 2015. Cited by 2,184 papers, by iCite.

Cite this record

ConductScience Library. The global burden of IBD: from 2015 to 2025. Papers, record 26323879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323879

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The global burden of IBD: from 2015 to 2025.
PubMed
Journal
Nat Rev Gastroenterol Hepatol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
2,184
iCite
Relative citation ratio, by iCite
80.1
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaplan GGGilaad G

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cost of IllnessMajor topic
Inflammatory Bowel DiseasesMajor topic
Environmental Exposure
Environmental Monitoring
Humans

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Canadian Institutes of Health ResearchCanadaPubMed

Source PubMed

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04733456Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) PatientsBackgroundClinicalTrials.gov
NCT05611866A Pilot Study of FMT on CD Patients With AIECBackgroundClinicalTrials.gov
NCT06553053Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority TrialBackgroundClinicalTrials.gov

Download CSV of trials

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119651626Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.Gut2009https://conductscience.org/library/papers/19651626PubMed
223516681Environment and the inflammatory bowel diseases.Can J Gastroenterol2013https://conductscience.org/library/papers/23516681PubMed
311266373Smoking cessation and the course of Crohn's disease: an intervention study.Gastroenterology2001https://conductscience.org/library/papers/11266373PubMed
42598752A meta-analysis of the role of smoking in inflammatory bowel disease.Dig Dis Sci1989https://conductscience.org/library/papers/2598752PubMed
514570727Incidence and prevalence of ulcerative colitis in Punjab, North India.Gut2003https://conductscience.org/library/papers/14570727PubMed
611085842The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.Ann Intern Med2000https://conductscience.org/library/papers/11085842PubMed
726055136Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies.Gastroenterology2015https://conductscience.org/library/papers/26055136PubMed
819572377Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies.Inflamm Bowel Dis2010https://conductscience.org/library/papers/19572377PubMed
923604131East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.Gut2014https://conductscience.org/library/papers/23604131PubMed
1024832837Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries.Eur J Health Econ2014https://conductscience.org/library/papers/24832837PubMed
1125350768Funding a smoking cessation program for Crohn's disease: an economic evaluation.Am J Gastroenterol2015https://conductscience.org/library/papers/25350768PubMed
1219466305Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil.Arq Gastroenterol2009https://conductscience.org/library/papers/19466305PubMed
1323128233Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.Nature2012https://conductscience.org/library/papers/23128233PubMed
1423166905Inflammatory bowel disease: a Canadian burden of illness review.Can J Gastroenterol2012https://conductscience.org/library/papers/23166905PubMed
1525223575Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.Am J Gastroenterol2014https://conductscience.org/library/papers/25223575PubMed
1612290760Health policy in less developed countries: past trends and future directions.J Int Dev1995https://conductscience.org/library/papers/12290760PubMed
1715168363Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.Gastroenterology2004https://conductscience.org/library/papers/15168363PubMed
1825732745Epidemiology and risk factors for IBD.Nat Rev Gastroenterol Hepatol2015https://conductscience.org/library/papers/25732745PubMed
1924037875Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.Gut2013https://conductscience.org/library/papers/24037875PubMed
2014687822Risk of early surgery for Crohn's disease: implications for early treatment strategies.Am J Gastroenterol2003https://conductscience.org/library/papers/14687822PubMed

See all 75 referencesDownload CSV of references

Cited by1,394

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,184 citations.

PMIDTitleJournalYearIn PapersSource
42979275A probiotic-drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979275PubMed
42952690Associations between redox-related biomarkers and treatment response in patients with inflammatory bowel disease initiating infliximab or vedolizumab.Front Pharmacol2026https://conductscience.org/library/papers/42952690PubMed
42920913Targeting miR-21 ameliorates colitis by restoring Th17/Treg balance through direct inhibition of Smad7/Ski.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42920913PubMed
42909122Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline.Front Pharmacol2026https://conductscience.org/library/papers/42909122PubMed
42899159The aryl hydrocarbon receptor and kynurenine pathway: connecting inflammatory bowel disease and depression via the microbiota gut brain axis.Front Neurosci2026https://conductscience.org/library/papers/42899159PubMed
42897465Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) for inflammatory bowel disease: a systematic review and bivariate diagnostic meta-analysis.BMC Gastroenterol2026https://conductscience.org/library/papers/42897465PubMed
42866443Alternative Medicine and Nutritional Therapy in Adult Inflammatory Bowel Disease in India: A Move Towards Holistic Practice.Cureus2026https://conductscience.org/library/papers/42866443PubMed
42851492Ulcerative colitis, but not Crohn's disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification.Front Immunol2026https://conductscience.org/library/papers/42851492PubMed
42823103
Patient outcomes and healthcare utilisation following implementation of an advanced therapy care pathway for inflammatory bowel disease: a multicentre, prospective quasi-experimental preimplementation/postimplementation study in the Netherlands.
BMJ Open Gastroenterol2026https://conductscience.org/library/papers/42823103PubMed
42812064[Ethyl caffeate alleviates dextran sulfate sodium-induced colitis in mice by restoring intestinal epithelial tight junctions via activating the Wnt/β-Catenin pathway].Nan Fang Yi Ke Da Xue Xue Bao2026https://conductscience.org/library/papers/42812064PubMed
42801564Integrating Genetics With Epidemiological Measurements Identifies Burden QTLs of Inflammatory Bowel Disease across 20 Countries.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42801564PubMed
42783218Associations Between Anti-TNF Pharmacokinetics, Immunogenicity, and Therapeutic Response in Iraqi Patients with Inflammatory Bowel Disease: A Real-World Therapeutic Drug Monitoring Study.Diseases2026https://conductscience.org/library/papers/42783218PubMed
42781199Microplastics and nanoplastics in inflammatory bowel disease: Mechanistic plausibility, human evidence and future research priorities.World J Gastrointest Pathophysiol2026https://conductscience.org/library/papers/42781199PubMed
42780487Biohybrid magnetic carrier robots for targeted bacteria release in ulcerative colitis.Mater Today Bio2026https://conductscience.org/library/papers/42780487PubMed
42760344The exposome and inflammatory bowel disease: a framework for primary and primordial prevention.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/42760344PubMed
42756163Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment.Front Immunol2026https://conductscience.org/library/papers/42756163PubMed
42725754Adhesion-Enhanced Engineered Probiotic for Prolonged Intestinal Retention and Calprotectin-Responsive IBD Therapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42725754PubMed
42708056Colon-targeted oral delivery of melatonin for regulating macrophage activity and intestinal barrier in ulcerative colitis.Theranostics2026https://conductscience.org/library/papers/42708056PubMed
42688144The algorithmic epistemic inversion in gastroenterology: how social media and psychological vulnerability fuel secondary risks in IBD and IBS management.Front Public Health2026https://conductscience.org/library/papers/42688144PubMed
42688076IBD-related inflammatory memory and colorectal cancer: epigenetic mechanisms and microbiome interventions.Front Immunol2026https://conductscience.org/library/papers/42688076PubMed

See all 1,394 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26323879

GET https://conductscience.org/api/papers/v1/26323879/references?page=2